Latest filing published 02 May 2023 for Alzamend Neuro, Inc., €18k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -90.2%Entry US$676.35 · Close at T+365 US$66.15
- -82.5%Entry US$1,768.50 · Close at T+365 US$309.15
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Stephan Jackman: trading record in brief
This profile gathers the share dealings of Stephan Jackman in Alzamend Neuro, Inc. Between 19 September 2022 and 28 April 2023, the trades on record add up to 2 filings.
On the market, this insider has only ever bought: 2 purchases, €29k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2023 to date brings 1 purchase and no sales.
Most recently, on 2 May 2023, the filings show an open-market purchase worth €18k in Alzamend Neuro, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Stephan Jackman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 37,000 shares@ US$0.540563.6% of flowCommon StockSEC:0001214659-23-006373:0Canonical exit: 27 Jul 2023 (T+90)
- 8,500 shares@ US$1.225236.4% of flowCommon StockSEC:0001214659-22-011325:0Canonical exit: 18 Dec 2022 (T+90)
2 of 2 declarations